Amphastar Pharmaceuticals, Inc. (AMPH) 当前追踪市盈率 (P/E) 为 9.7, 前瞻市盈率为 6.5. 追踪盈利收益率为 10.30%, 前瞻盈利收益率 15.29%. PEG 0.11 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $28.74.
本页证实的标准:
SharesGrow 综合评分： 71/100 其中 4/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 79.4 | -0.17 | 2.54 | 3.28 | - |
| 2017 | 196.8 | -3.48 | 2.63 | 3.69 | - |
| 2018 | -160.9 | 0.73 | 2.78 | 3.13 | - |
| 2019 | 18.5 | -0.02 | 2.38 | 2.81 | - |
| 2020 | 674.2 | -6.94 | 2.35 | 2.70 | - |
| 2021 | 17.9 | 0.00 | 2.50 | 2.54 | - |
| 2022 | 14.9 | 0.33 | 2.57 | 2.73 | - |
| 2023 | 21.7 | 0.42 | 4.67 | 4.63 | - |
| 2024 | 11.3 | 0.73 | 2.46 | 2.46 | - |
| 2025 | 12.8 | -0.35 | 1.59 | 1.74 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $0.22 | $255.17M | $10.53M | 4.1% |
| 2017 | $0.09 | $240.18M | $4.51M | 1.9% |
| 2018 | $-0.12 | $294.67M | $-5.74M | -1.9% |
| 2019 | $0.98 | $322.36M | $48.94M | 15.2% |
| 2020 | $0.02 | $349.85M | $1.1M | 0.3% |
| 2021 | $1.25 | $437.77M | $62.12M | 14.2% |
| 2022 | $1.74 | $498.99M | $91.39M | 18.3% |
| 2023 | $2.60 | $644.4M | $137.55M | 21.3% |
| 2024 | $3.06 | $712.81M | $159.52M | 22.4% |
| 2025 | $2.03 | $719.89M | $98.09M | 13.6% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $3.28 | $3.17 – $3.46 | $756.52M | $746.77M – $766.26M | 3 |
| 2027 | $3.49 | $3.23 – $3.68 | $792.55M | $788.96M – $796.14M | 3 |
| 2028 | $3.62 | $3.52 – $3.70 | $824.16M | $824.14M – $824.18M | 1 |
| 2029 | $3.02 | $2.94 – $3.09 | $881M | $862.56M – $897.18M | 1 |
| 2030 | $3.00 | $2.92 – $3.07 | $905M | $886.06M – $921.63M | 1 |
